换一批Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
第一作者：
Tamar,Perri
第一单位：
Department of Gynecologic Oncology, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Ramat-Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel. Electronic address: tamarperri@gmail.com.
作者：
医学主题词
腹部(Abdomen);成年人(Adult);年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);CA-125抗原(CA-125 Antigen);癌(Carcinoma);化学疗法, 辅助(Chemotherapy, Adjuvant);无病生存(Disease-Free Survival);输卵管肿瘤(Fallopian Tube Neoplasms);女(雌)性(Female);人类(Humans);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);肿瘤, 残余(Neoplasm, Residual);卵巢肿瘤(Ovarian Neoplasms);骨盆(Pelvis);腹膜肿瘤(Peritoneal Neoplasms);胸腔积液, 恶性(Pleural Effusion, Malignant);回顾性研究(Retrospective Studies);胸外科手术, 电视辅助(Thoracic Surgery, Video-Assisted);胸部(Thorax)
DOI
10.1016/j.ygyno.2013.07.093
PMID
23880152
发布时间
2013-10-07
- 浏览44
Gynecologic oncology
27-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
